{"id":797865,"date":"2025-01-06T07:09:48","date_gmt":"2025-01-06T12:09:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/"},"modified":"2025-01-06T07:09:48","modified_gmt":"2025-01-06T12:09:48","slug":"in8bio-to-present-at-biotech-showcase-2025-in-san-francisco","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/","title":{"rendered":"IN8bio to Present at Biotech Showcase 2025 in San Francisco"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, Jan.  06, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AhkaqsiWyN7D5BgU61mBiHLaSMcbV6C57HYFePJFiet1jaSnbjC16o8Ys6MgX8tqxrSHDaXvAvvU_3in1rR9HA==\" rel=\"nofollow\" target=\"_blank\">IN8bio, Inc.<\/a> (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced William Ho, CEO and co-founder, will participate at Biotech Showcase 2025 on a panel on Monday, January 13, 2025, and present on Tuesday, January 14, 2025, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Details for the event are provided below.<\/p>\n<p>\n        <strong>Biotech Showcase, January 13 &#8211; 15, 2025<\/strong>\n      <\/p>\n<p>Panel: The Battle Against Cancer: The Armamentarium Keeps Expanding<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Date: Monday, January 13, 2025<\/li>\n<li style=\"margin-bottom:8pt\">Time: 8:00 AM PT<\/li>\n<li style=\"margin-bottom:8pt\">Track: Yosemite C (Ballroom Level)<\/li>\n<\/ul>\n<p>Corporate presentation<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Date: Tuesday, January 14, 2025<\/li>\n<li style=\"margin-bottom:8pt\">Time: 2:00 PM PT<\/li>\n<li style=\"margin-bottom:8pt\">Track: Yosemite A (Ballroom Level)<\/li>\n<li style=\"margin-bottom:8pt\"> Live webcast:\u00a0<a href=\"https:\/\/event.webcasts.com\/starthere.jsp?ei=1703689&amp;tp_key=9d7f185675\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.webcasts.com\/starthere.jsp?ei=1703689&amp;tp_key=9d7f185675<\/a><\/li>\n<\/ul>\n<p>Interested parties can register to attend the event here: https:\/\/informaconnect.com\/biotech-showcase\/registration-options\/<\/p>\n<p>Additionally, IN8bio management will be in San Francisco from January 13-16, 2025, during the 43rd Annual J.P. Morgan Health Care Conference and will be available for meetings with investors. Individuals interested in meeting with IN8bio management can contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qopnUw-FTAwOS8XXq_uNYwPdj2oqgaW2LQ85b9dELjiTxSBcII1uhMC-4Bg0k0pxfM0y1D_9WaCahFSJIHKq-L-UZb7s7bEjuA0BkrNeLoo=\" rel=\"nofollow\" target=\"_blank\">gdschulman@in8bio.com<\/a>.<\/p>\n<p>\n        <strong>About IN8bio<\/strong>\n      <\/p>\n<p>IN8bio is a clinical-stage biopharmaceutical company developing gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate between healthy and diseased tissue. The company\u2019s lead program, INB-100, is focused on AML evaluating haplo-matched allogeneic gamma-delta T cells given to patients following a hematopoietic stem cell transplant. The company is also evaluating autologous DeltEx DRI gamma-delta T cells, in combination with standard of care, for glioblastoma. For more information about IN8bio, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtMhnPb-sGa5bGznX_SNdC8WX5gpbg1hiJ8W9vfKKrTYxTAU0DSyO1VAH-DFvYhLcS_9-syDTBcbknik13xjuw==\" rel=\"nofollow\" target=\"_blank\">www.IN8bio.com<\/a>.<\/p>\n<p>\n        <strong>Investors &amp; Company Contacts<\/strong>\n      <\/p>\n<p>Glenn Schulman, PharmD, MPH<br \/>203.494.7411<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qopnUw-FTAwOS8XXq_uNYwPdj2oqgaW2LQ85b9dELjg7bJuweWrv4SVPki_t8rmIi0EGLldFtgwmDeGuHo0aQ0wm0TSVWXdmZnpykHx2318=\" rel=\"nofollow\" target=\"_blank\">gdschulman@in8bio.com<\/a><\/p>\n<p>IN8bio, Inc.<br \/>Patrick McCall<br \/>646.933.5603<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pFdWTFk_rlY23QwolD5Rt3aTg8l9hqcmZLSusEHwiMRJHNJod0EZVJUZagRDf6SIjCpzpClUlsLEr-0dIVfGlvOJjtgai4EXc60OXjJTMTM=\" rel=\"nofollow\" target=\"_blank\">pfmccall@IN8bio.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Kimberly Ha<br \/>KKH Advisors<br \/>917.291.5744<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fV81qoc6TVCu1A2AI92pFS1wct1DCGOW0LIvLaSJR06_0RNUPmLdykme4jcKabHRZNlGmlhNLbZ328VUnWBx6evSmLWBeUCdKmNmOMfhDS3tmQdc8L1R_7l1_MFdBEtS\" rel=\"nofollow\" target=\"_blank\">kimberly.ha@kkhadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDUyMGYwMGEtMmY2YS00OGMyLTliZTMtNjIyNzI4YWFhYmExLTExMzQ1Nzc=\/tiny\/IN8bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced William Ho, CEO and co-founder, will participate at Biotech Showcase 2025 on a panel on Monday, January 13, 2025, and present on Tuesday, January 14, 2025, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Details for the event are provided below. Biotech Showcase, January 13 &#8211; 15, 2025 Panel: The Battle Against Cancer: The Armamentarium Keeps Expanding Date: Monday, January 13, 2025 Time: 8:00 AM PT Track: Yosemite C (Ballroom Level) Corporate presentation Date: Tuesday, January 14, 2025 Time: 2:00 PM PT Track: Yosemite A (Ballroom Level) Live webcast:\u00a0https:\/\/event.webcasts.com\/starthere.jsp?ei=1703689&amp;tp_key=9d7f185675 Interested parties can &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IN8bio to Present at Biotech Showcase 2025 in San Francisco&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-797865","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced William Ho, CEO and co-founder, will participate at Biotech Showcase 2025 on a panel on Monday, January 13, 2025, and present on Tuesday, January 14, 2025, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Details for the event are provided below. Biotech Showcase, January 13 &#8211; 15, 2025 Panel: The Battle Against Cancer: The Armamentarium Keeps Expanding Date: Monday, January 13, 2025 Time: 8:00 AM PT Track: Yosemite C (Ballroom Level) Corporate presentation Date: Tuesday, January 14, 2025 Time: 2:00 PM PT Track: Yosemite A (Ballroom Level) Live webcast:\u00a0https:\/\/event.webcasts.com\/starthere.jsp?ei=1703689&amp;tp_key=9d7f185675 Interested parties can &hellip; Continue reading &quot;IN8bio to Present at Biotech Showcase 2025 in San Francisco&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-06T12:09:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IN8bio to Present at Biotech Showcase 2025 in San Francisco\",\"datePublished\":\"2025-01-06T12:09:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/\"},\"wordCount\":309,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/\",\"name\":\"IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\",\"datePublished\":\"2025-01-06T12:09:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IN8bio to Present at Biotech Showcase 2025 in San Francisco\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/","og_locale":"en_US","og_type":"article","og_title":"IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk","og_description":"NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced William Ho, CEO and co-founder, will participate at Biotech Showcase 2025 on a panel on Monday, January 13, 2025, and present on Tuesday, January 14, 2025, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Details for the event are provided below. Biotech Showcase, January 13 &#8211; 15, 2025 Panel: The Battle Against Cancer: The Armamentarium Keeps Expanding Date: Monday, January 13, 2025 Time: 8:00 AM PT Track: Yosemite C (Ballroom Level) Corporate presentation Date: Tuesday, January 14, 2025 Time: 2:00 PM PT Track: Yosemite A (Ballroom Level) Live webcast:\u00a0https:\/\/event.webcasts.com\/starthere.jsp?ei=1703689&amp;tp_key=9d7f185675 Interested parties can &hellip; Continue reading \"IN8bio to Present at Biotech Showcase 2025 in San Francisco\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-06T12:09:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IN8bio to Present at Biotech Showcase 2025 in San Francisco","datePublished":"2025-01-06T12:09:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/"},"wordCount":309,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/","name":"IN8bio to Present at Biotech Showcase 2025 in San Francisco - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=","datePublished":"2025-01-06T12:09:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjc5MSM2NjQ2MjIzIzIxMjMwMDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/in8bio-to-present-at-biotech-showcase-2025-in-san-francisco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IN8bio to Present at Biotech Showcase 2025 in San Francisco"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=797865"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797865\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=797865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=797865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=797865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}